SMARCA2 and cancer: In some cases, synthetic lethality is caused by the concomitant knockout of two mutually exclusive paralogues [69]: Tumours with a SMARCA4 deficiency are sensitive to SMARCA2 depletion [65], and ARID1B is required for survival of ARID1A-mutant cancers [7].